Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues:
Product royalty revenues		$ 34,225
Research fees	14,200	193,238
Contract revenue	30,049,600	2,000
Total Revenue:	30,063,800	229,463
Cost of product royalties	375,000	297,419
Expenses:
Research and development	4,711,610	6,690,674
General and administrative	2,840,795	1,764,489
Related party general and administrative, net	26,250	18,750
Total Expenses:	7,578,655	8,473,913
Income (loss) from operations	22,110,145	(8,541,869)
Interest income	56,616	37,784
Derivative loss	(1,867,246)	(487,313)
Other expense, net	(3,464)	(27,913)
Net income (loss)	$ 20,296,051	$ (9,019,311)
Basic:
Weighted average common stock shares outstanding	29,561,655	25,105,563
Basic earnings per share	$ 0.69	$ (0.36)
Diluted:
Diluted weighted average common stock shares outstanding	29,586,036	25,105,563
Diluted earnings per share	$ 0.69	$ (0.36)